October 5-6, 2021
Virtual Meeting

conference cochairs

Johanna A. Joyce, University of Lausanne, Lausanne, Switzerland
Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center, Houston, Texas
Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, New York

This AACR Virtual Special Conference on Tumor Immunology and Immunotherapy is designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists to develop approaches that translate to outcomes. This year’s program will feature international leaders in the field, who will expand our knowledge of the immune landscape of cancer; immunometabolism; immune cell engineering; and systems biology and new technology. World-renowned oncologists and researchers will offer their insights on COVID-19 immunology in cancer patients; therapeutic targeting of the tumor microenvironment; and combinatorial studies to overcome resistance to immunotherapy. Attendees are encouraged to join in the conversation and network with investigators, from basic to translational scientists, from academia to industry.

Lead Supporter

Bristol Myers Squibb

Cure Supporter

Janssen

professional educational grants

AstraZeneca
GlaxoSmithKline
Merck
Pfizer

Progress Supporter

Genmab

#AACRtii21

*Original image courtesy of Spencer Watson, postdoctoral fellow, University of Lausanne